William A. Weiss

Active 1958–2025

125
Papers
27,089
Citations
84
h-index
123
i10-index

Citations

Citations per year for William A. Weiss1958: 1 citations1971: 1 citations1973: 1 citations1976: 1 citations1977: 1 citations1978: 1 citations1979: 2 citations1980: 1 citations1982: 1 citations1983: 1 citations1986: 1 citations1988: 4 citations1989: 3 citations1990: 4 citations1991: 3 citations1992: 3 citations1993: 2 citations1994: 1 citations1995: 4 citations1996: 2 citations1997: 1 citations1998: 4 citations1999: 8 citations2000: 2 citations2001: 10 citations2002: 7 citations2003: 13 citations2004: 20 citations2005: 21 citations2006: 62 citations2007: 106 citations2008: 121 citations2009: 161 citations2010: 211 citations2011: 217 citations2012: 311 citations2013: 333 citations2014: 402 citations2015: 368 citations2016: 362 citations2017: 403 citations2018: 358 citations2019: 1,170 citations2020: 1,145 citations2021: 1,224 citations2022: 885 citations2023: 692 citations2024: 967 citations2025: 442 citations2026: 19 citations1959–1970: no citations, so these years are not shown1972: no citations, so this year is not shown1974–1975: no citations, so these years are not shown1981: no citations, so this year is not shown1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,885 citing papers, 29% of this breakdownChina: 1,506 citing papers, 11.3% of this breakdownUnited Kingdom: 914 citing papers, 6.8% of this breakdownGermany: 877 citing papers, 6.6% of this breakdownCanada: 608 citing papers, 4.5% of this breakdownItaly: 540 citing papers, 4% of this breakdownFrance: 480 citing papers, 3.6% of this breakdownAustralia: 348 citing papers, 2.6% of this breakdownNetherlands: 337 citing papers, 2.5% of this breakdownSwitzerland: 321 citing papers, 2.4% of this breakdownJapan: 320 citing papers, 2.4% of this breakdownSpain: 308 citing papers, 2.3% of this breakdown
0%29%Other 22%

Fields

  • Medicine47%
  • Biochemistry, Genetics and Molecular Biology44.2%
  • Immunology and Microbiology2.9%
  • Neuroscience2%
  • Engineering0.9%
  • Chemistry0.8%
  • Other2.2%

Topics

  • Glioma Diagnosis and Treatment8.1%
  • Neuroblastoma Research and Treatments4.9%
  • Epigenetics and DNA Methylation2.8%
  • MicroRNA in disease regulation2.8%
  • Cancer, Hypoxia, and Metabolism2.7%
  • Protein Degradation and Inhibitors2.5%
  • Other76.2%

Coauthors

All papers

Open in search
  1. Neuroblastoma

    Authors: , , , , , , - Nature Reviews Disease Primers 2016 cited by 1,428

  2. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies

    Authors: , , , , - Oncogene 2018 cited by 663

  3. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricardo A. Fernandes, Michelle Monje, Jennifer R. Cochran, Poul H. Sorensen, Heike E. Daldrup‐Link, Irving L. Weissman, Julien Sage, Ravindra Majeti, Carolyn R. Bertozzi, William A. Weiss, Crystal L. Mackall, Robbie G. Majzner - Nature Medicine 2022 cited by 255

  4. Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian F. Pollack, Ronald L. Hamilton, G. Yancey Gillespie, James M. Olson, Sarah Leary, William A. Weiss, Bolesław Lach, Lola B. Chambless, Reid C. Thompson, Michael K. Cooper, Rajeev Vibhakar, Péter Hauser, Marie‐Lise C. van Veelen, Johan M. Kros, Pim J. French, Young Seob Shin, Toshihiro Kumabe, Enrique López‐Aguilar, Karel Zitterbart, Jaroslav Štěrba, Gaetano Finocchiaro, Maura Massimino, Erwin G. Van Meir, Satoru Osuka, Tomoko Shofuda, Álmos Klekner, Massimo Zollo, Jeffrey R. Leonard, Joshua B. Rubin, Nada Jabado, Steffen Albrecht, Jaume Mora, Timothy Van Meter, Shin Jung, Andrew S. Moore, Andrew R. Hallahan, Jennifer A. Chan, Daniela Pretti da Cunha Tirapelli, Carlos Gilberto Carlotti, Maryam Fouladi, José Pimentel, Cláudia C. Faria, Ali G. Saad, Luca Massimi, Linda M. Liau, Helen Wheeler, Hideo Nakamura, Samer K. Elbabaa, Mario Pérezpeña-Díazconti, Fernando Chico Ponce de León, Shenandoah Robinson, Michal Zápotocký, Álvaro Lassaletta, Annie Huang, Cynthia Hawkins, Uri Tabori, Éric Bouffet, Ute Bartels, Peter B. Dirks, James T. Rutka, Gary D. Bader, Jüri Reimand, Anna Goldenberg, Vijay Ramaswamy, Michael D. Taylor - Cancer Cell 2017 cited by 1,255

  5. Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitchel S. Berger, Susan M. Chang, Barry S. Taylor, J Costello - Science 2013 cited by 1,404

  6. Neuroblastoma and MYCN

    Authors: , - Cold Spring Harbor Perspectives in Medicine 2013 cited by 643

  7. An expanded universe of cancer targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew L. Kung, Brent R. Stockwell, Jesse S. Boehm, Josh Dempster, Robert T. Manguso, Francisca Vázquez, Lee Cooper, Yuhong Du, Andrei A. Ivanov, Sagar Lonial, Carlos S. Moreno, Qiankun Niu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Matthew A. Reyna, Wei Zhou, Carla Grandori, Ilya Shmulevich, Elizabeth M. Swisher, Jitong Cai, Issac S. Chan, Matthew Dunworth, Yuchen Ge, Dan Georgess, Eloïse M. Grasset, Elodie Henriet, Hildur Knútsdóttir, Michael G. Lerner, Veena Padmanaban, Matthew C. Perrone, Yasir Suhail, Yohannes Tsehay, Manisha Warrier, Quin Morrow, Tamilla Nechiporuk, Nicola Long, Jennifer N. Saultz, Andy Kaempf, Jessica Minnier, Cristina E. Tognon, Stephen E. Kurtz, Anupriya Agarwal, Jordana F. Brown, Kevin Watanabe‐Smith, Tania Q. Vu, Thomas Jacob, Yunqi Yan, Bridget A. Robinson, Evan Lind, Yoko Kosaka, Emek Demir, Joseph Estabrook, Michael Grzadkowski, Olga Nikolova, Ken Chen, Ben Deneen, Han Liang, Michael C. Bassik, Asmita Bhattacharya, Kevin Brennan, Christina Curtis, Olivier Gevaert, Hanlee P. Ji, Kasper Karlsson, Kremena Karagyozova, Yuan‐Hung Lo, Katherine Liu, Michitaka Nakano, Anuja Sathe, Amber R. Smith and 25 more - Cell 2021 cited by 224

  8. A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling

    Authors: , , , , , , , , , , , , , - Cell 2006 cited by 1,154

  9. Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yisu Li, Allan Lo, Karen Mungall, Ka Ming Nip, Jenny Q. Qian, Anthony Raymond, Nina Thiessen, Richard Varhol, İnanç Birol, Richard A. Moore, Andrew J. Mungall, Robert A. Holt, Daisuke Kawauchi, Martine F. Roussel, Marcel Kool, David Jones, Hendrick Witt, Africa Fernández-L, Anna Marie Kenney, Robert J. Wechsler‐Reya, Peter B. Dirks, Tzvi Aviv, Wiesława Grajkowska, Marta Perek‐Polnik, Christine Haberler, Olivier Delattre, Stéphanie Reynaud, François Doz, Sarah S. Pernet-Fattet, Byung-Kyu Cho, Seung‐Ki Kim, Kyu‐Chang Wang, Wolfram Scheurlen, Charles G. Eberhart, Michelle Fèvre‐Montange, Anne Jouvet, Ian F. Pollack, Xing Fan, Karin M. Muraszko, G. Yancey Gillespie, Concezio Di Rocco, Luca Massimi, Erna Michiels, Nanne K. Kloosterhof, Pim J. French, Johan M. Kros, James M. Olson, Richard G. Ellenbogen, Karel Zitterbart, Leoš Křen, Reid C. Thompson, Michael K. Cooper, Bolesław Lach, Roger E. McLendon, Darell D. Bigner, Adam M. Fontebasso, Steffen Albrecht, Nada Jabado, Janet C. Lindsey, Simon Bailey, Nalin Gupta, William A. Weiss, László Bognár, Álmos Klekner, Timothy Van Meter, Toshihiro Kumabe, Teiji Tominaga, Samer K. Elbabaa, Jeffrey R. Leonard, Joshua B. Rubin and 35 more - Nature 2012 cited by 931

  10. Principles and Current Strategies for Targeting Autophagy for Cancer Treatment

    Authors: , , , , , , , , - Clinical Cancer Research 2011 cited by 898

  11. Brain-restricted mTOR inhibition with binary pharmacology

    Authors: , , , , , - Nature 2022 cited by 85

  12. Targeted expression of MYCN causes neuroblastoma in transgenic mice

    Authors: , , , , - The EMBO Journal 1997 cited by 871

  13. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 263

  14. Pediatric high-grade glioma: biologically and clinically in need of new thinking

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2016 cited by 364

  15. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 cited by 112

  16. MYC phase separation selectively modulates the transcriptome

    Authors: , , , , , , , , , , , , , - Nature Structural & Molecular Biology 2024 cited by 49

  17. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

    Authors: , , , , , , , , , , , , , - BMC Medicine 2008 cited by 948

  18. A robust method to derive functional neural crest cells from human pluripotent stem cells.

    Authors: , , , , , , , , , - 2013 cited by 219

  19. Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

    Authors: , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 633

  20. Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johan M. Kros, Pim J. French, Nada Jabado, Ho‐Keung Ng, Wai Sang Poon, Charles G. Eberhart, Ian F. Pollack, James M. Olson, William A. Weiss, Toshihiro Kumabe, Enrique López‐Aguilar, Bolesław Lach, Maura Massimino, Erwin G. Van Meir, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Noriyuki Kijima, Álmos Klekner, László Bognár, Jennifer A. Chan, Cláudia C. Faria, Jiannis Ragoussis, Stefan M. Pfister, Anna Goldenberg, Robert J. Wechsler‐Reya, Swneke D. Bailey, Livia Garzia, A. Sorana Morrissy, Marco A. Marra, Xi Huang, David Malkin, Olivier Ayrault, Vijay Ramaswamy, Xosé S. Puente, John A. Calarco, Lincoln Stein, Michael D. Taylor - Nature 2019 cited by 173

  21. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William A. Weiss, Carol J. Thiele, Kimberly Stegmaier - Journal of Clinical Investigation 2017 cited by 160

  22. Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning

    Authors: , , , , , , , , , , , , , , - Neuro-Oncology 2022 cited by 57

  23. Drugging MYCN through an Allosteric Transition in Aurora Kinase A

    Authors: , , , , , , , , , , , , - Cancer Cell 2014 cited by 279

  24. EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma

    Authors: , , , , , , , , , , , , , - Cancer Cell 2013 cited by 263